Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
Timmers, L., Keulen, J.K. van, Höfer, I.E., Meijs, M.F.L., Middelaar, B.J. van, Ouden, K. den, Echteld, C.J.A. van, Pasterkamp, G. & Kleijn, D.P.V. de (2009). Circulation Research, (ISSN 0009-7330), 104, 699-706 (2009)
The active confirmation of von Willebrand Factor in patients with thrombotic thrombocytopenic purpura in remission. Groot, E., Fijnheer, R., Sebastian, S.A.E., Groot, P.G. de, & Lenting P.J. (2009). Journal of Thrombosis and Haemostasis, (ISSN 1538-7933), 7, 962-969 (2009)
Paraoxonase variants relate to 10-year risk in coronary artery disease: impact of a high-density lipoprotein-bound antioxidant in secondary prevention.
Regieli, J.J., Jukema, J.W., Doevendans, P.A., Zwinderman, A.H., Kastelein, J.J., Grobbee, D.E. & Graaf, Y. van der (2009). Paraoxonase variants relate to 10-year risk in coronary artery disease: impact of a high-density lipoprotein-bound antioxidant in secondary prevention. Journal of the American College of Cardiology, (ISSN 0735-1097), 54(14), 1238-1245 (2009)
Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology.
Smits, A.M., Vliet, P. van, Metz, C.H.G., Korfage, T.H., Sluijter, J.P.G., Doevendans, P.A.F.M. & Goumans, M.J. (2009). Nature Protocols, (ISSN 1754-2189), 4(2), 232-43 (2009)
Combined reduction of intercellular coupling and membrane excitability differentially affects transverse and longitudinal cardiac conduction. Stein, M., Veen, A.A.B. van, Remme, C.A., Boulaksil, M., Noorman, M., Stuijvenberg, L. van, Nagel, R. van der, Bezzina, C.R., Hauer, R.N.W., Bakker, J.M.T. de & Rijen, H.V.M. van (2009). Cardiovascular Research, (ISSN 0008-6363), 83(1), 52-60 (2009)